When bitter compounds activate these receptors in the gut, they stimulate GLP-1 secretion
Ingredients: Microcrystalline Cellulose, Vegetable Cellulose, Vegetable Magnesium Stearate, Silica
A Mayo Clinic study found postmenopausal women using hormone therapy alongside tirzepatide (a GLP-1/GIP dual agonist) experienced notably greater weight loss compared with those using tirzepatide without HRT
Specific insulin/IGF1 hybrid receptor activation assay reveals IGF1 as a more potent ligand than insulin
The right dose is the one that produces consistent results with tolerable side effects
Several well-established and widely prescribed GLP-1 receptor agonists, including various formulations of semaglutide, liraglutide, and dulaglutide, are administered via subcutaneous injection